LexDanaLexDanabeta
Inventor

Enzo Paoletti

Inventor
Delmar, NY, US

Overview

63→
Patents
1986–2010
Patent span
Chemistry
Primary field (CPC C)

Patents· 63 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes28%
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
Y02ATechnologies for adaptation to climate change3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
7,767,449'Methods using modified vaccinia virus'20107,255,862'ALVAC/FIV constructs'20077,144,578'Poxvirus-rabies recombinants and compositions and methods employing the recombinants'20066,780,407'Pox virus comprising DNA sequences encoding CEA and B7 antigen'20046,632,438'Recombinant poxvirus cytomegalovirus, compositions, and uses'20036,605,465'Methods for avoiding maternal immunity'20036,596,279'Immunodeficiency recombinant poxvirus'20036,537,594'Vaccina virus comprising cytokine and/or tumor associated antigen genes'20036,395,283'Equine herpesvirus type 1 glyocoprotein D (EHV-1gD)'20026,340,462'Recombinant avipox virus'20026,309,647'Poxvirus--canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants'20016,267,965'Recombinant poxvirus--cytomegalovirus compositions and uses'20016,265,189'Pox virus containing DNA encoding a cytokine and/or a tumor associated antigen'20016,248,333'Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)'20016,214,353'Malaria recombinant poxvirus vaccine'20016,183,750'Avipox virus containing DNA sequences encoding herpesvirus glycoproteins'20016,130,066'Vectors having enhanced expression and methods of making and uses thereof'20006,017,542'Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor'20006,004,777'Vectors having enhanced expression, and methods of making and uses thereof'19995,997,878'Recombinant poxvirus-cytomegalovirus, compositions and uses'19995,989,561'Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses'19995,990,091'Vectors having enhanced expression, and methods of making and uses thereof'19995,972,597'Methods using modified vaccinia virus'19995,942,235'Recombinant poxvirus compositions and methods of inducing immune responses'19995,891,442'Infectious bursal disease virus recombination poxvirus vaccine'19995,863,542'Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts'19995,858,373'Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them'19995,843,456'Alvac poxvirus-rabies compositions and combination compositions and uses'19985,833,975'Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence'19985,766,599'Trova fowl pox virus recombinants comprising heterologous inserts'19985,766,598'Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products'19985,766,597'Malaria recombinant poxviruses'19985,762,938'Modified recombinant vaccinia virus and expression vectors thereof'19985,759,553'Marek\'s disease virus recombinant poxvirus vaccine'19985,759,552'Marek\'s disease virus recombinant poxvirus vaccine'19985,759,841'Immunological composition of measles virus utilizing recombinant poxvirus'19985,756,102'Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants'19985,756,103'Alvac canarypox virus recombinants comprising heterlogous inserts'19985,756,101'Malaria recombinant poxvirus'19985,744,140'Flavivirus recombinant poxvirus vaccine'19985,744,141'Flavivirus recombinant poxvirus immunological composition'19985,688,920'Nucleotide and amino acid sequences for canine herpesvirus GB, GC and GD and uses therefor'19975,658,572'Infectious bursal disease virus recombinant poxvirus vaccine'19975,641,490'Infectious bursal disease virus recombinant poxvirus vaccine'19975,583,028'Recombinant vaccinia virus as DNA constructs encoding HSV glycoproteins'19965,529,780'Nucleotide and amino acid sequences of canine herpesvirus gB and gC'19965,514,375'Flavivirus recombinant poxvirus vaccine'19965,505,941'Recombinant avipox virus and method to induce an immune response'19965,503,834'Measles virus recombinant poxvirus vaccine'19965,494,807'NYVAC vaccinia virus recombinants comprising heterologous inserts'19965,482,713'Equine herpesvirus recombinant poxvirus vaccine'19965,453,364'Recombinant poxvirus host range selection system'19955,378,457'Interferon sensitive recombinant poxvirus vaccine'19955,364,773'Genetically engineered vaccine strain'19945,338,683'Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins'19945,225,336'Recombinant poxvirus host range selection system'19935,204,243'Recombinant poxvirus internal cores'19935,174,993'Recombinant avipox virus and immunological use thereof'19925,155,020'Recombinant poxvirus host range selection system'19925,110,587'Immunogenic composition comprising synthetically modified vaccinia virus'19924,769,330'Modified vaccinia virus and methods for making and using the same'19884,722,848'Method for immunizing animals with synthetically modified vaccinia virus'19884,603,112'Modified vaccinia virus'1986

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1986–2010Patents assigned to HEALTH RESEARCH INC (21)· patent assignee history
1986–2010Based in Delmar, NY, US· patent location history
1992–1996Based in Albany, NY, US· patent location history
1994–2003Patents assigned to VIROGENETICS CORP (35)· patent assignee history
1998–2001Patents assigned to PASTEUR MERIEUX SERUMS VACC (2)· patent assignee history
2001–2004Patents assigned to AVENTIS PASTEUR (2)· patent assignee history
2006–2007Patents assigned to CONNAUGHT TECHNOLOGY CORP (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VIROGENETICS CORP351994–2003
HEALTH RESEARCH INC211986–2010
AVENTIS PASTEUR22001–2004
CONNAUGHT TECHNOLOGY CORP22006–2007
PASTEUR MERIEUX SERUMS VACC21998–2001
Locations
LocationPatentsSpan
Delmar, New York, US561986–2010
Albany, New York, US71992–1996